$CRTG
CORETEC GROUP INC. Stock $crtg

$crtg Overview Financials Valuation SEC Filings Company Website

2021 Q3 Form 10-Q Financial Statement

#000143774921019381 Filed on August 11, 2021

Income Statement

Concept	2021 Q3	2021 Q2	2020 Q2
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.481M	$2.517M	$212.9K
YoY Change	684.09%	1082.16%	24.99%
% of Gross Profit
Research & Development	$192.3K	$198.4K	$36.10K
YoY Change	416.86%	449.63%	79.97%
% of Gross Profit
Depreciation & Amortization	$20.65K	$20.06K	$20.06K
YoY Change	2.99%	0.0%	-0.89%
% of Gross Profit
Operating Expenses	$192.3K	$198.4K	$36.10K
YoY Change	416.86%	449.63%	79.97%
Operating Profit
YoY Change
Interest Expense	$44.08K	$72.58K	$56.65K
YoY Change	-45.27%	28.12%	-40.64%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$2.672M	-$2.788M	-$289.6K
YoY Change	515.51%	862.66%	1.32%
Income Tax
% Of Pretax Income
Net Earnings	-$2.672M	-$2.788M	-$289.6K
YoY Change	515.5%	862.65%	1.32%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.01	-$0.01
Diluted Earnings Per Share	-$10.60K	-$11.29K	-$1.429K
COMMON SHARES
Basic Shares Outstanding	252.3M	247.1M	202.7M
Diluted Shares Outstanding

Balance Sheet

Concept	2021 Q3	2021 Q2	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.357M	$4.817M	$107.8K
YoY Change	18315.64%	4369.04%	218.5%
Cash & Equivalents	$4.357M	$4.817M	$107.8K
Short-Term Investments
Other Short-Term Assets	$127.6K	$110.2K	$33.34K
YoY Change	-28.48%	230.53%	-9.75%
Inventory
Prepaid Expenses	$127.6K	$110.2K	$33.34K
Receivables
Other Receivables
Total Short-Term Assets	$4.485M	$4.927M	$141.1K
YoY Change	2119.57%	3391.33%	99.37%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill	$166.0K	$166.0K	$166.0K
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$7.200K	$31.70K	$3.580K
YoY Change	471.43%	785.47%	54.31%
Total Long-Term Assets	$1.183M	$1.229M	$1.269M
YoY Change	-5.05%	-3.16%	-5.89%
TOTAL ASSETS
Total Short-Term Assets	$4.485M	$4.927M	$141.1K
Total Long-Term Assets	$1.183M	$1.229M	$1.269M
Total Assets	$5.668M	$6.156M	$1.410M
YoY Change	291.34%	336.61%	-0.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$311.2K	$319.9K	$478.2K
YoY Change	-36.7%	-33.1%	-33.55%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$5.590K
YoY Change	-100.0%	-100.0%	-91.79%
Long-Term Debt Due	$407.9K
YoY Change
Total Short-Term Liabilities	$719.2K	$319.9K	$483.8K
YoY Change	28.15%	-33.87%	-85.83%
LONG-TERM LIABILITIES
Long-Term Debt	$793.1K	$1.229M	$186.3K
YoY Change	229.13%	559.86%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$793.1K	$1.229M	$186.3K
YoY Change	229.13%	559.86%
TOTAL LIABILITIES
Total Short-Term Liabilities	$719.2K	$319.9K	$483.8K
Total Long-Term Liabilities	$793.1K	$1.229M	$186.3K
Total Liabilities	$1.512M	$1.549M	$670.0K
YoY Change	88.52%	131.17%	-80.37%
SHAREHOLDERS EQUITY
Retained Earnings	-$13.11M	-$10.44M	-$6.314M
YoY Change	94.3%	65.34%	49.48%
Common Stock	$50.46K	$50.28K	$40.71K
YoY Change	23.39%	23.5%	191.12%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.156M	$4.607M	$739.8K
YoY Change
Total Liabilities & Shareholders Equity	$5.668M	$6.156M	$1.410M
YoY Change	291.34%	336.61%	-0.64%

Cashflow Statement

Concept	2021 Q3	2021 Q2	2020 Q2
OPERATING ACTIVITIES
Net Income	-$2.672M	-$2.788M	-$289.6K
YoY Change	515.5%	862.65%	1.32%
Depreciation, Depletion And Amortization	$20.65K	$20.06K	$20.06K
YoY Change	2.99%	0.0%	-0.89%
Cash From Operating Activities	-$415.6K	-$375.5K	-$295.5K
YoY Change	0.26%	27.11%	161.69%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$12.01K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	-$12.01K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-43.92K	-23.40K	322.7K
YoY Change	-113.29%	-107.25%	120.03%
NET CHANGE
Cash From Operating Activities	-415.6K	-375.5K	-295.5K
Cash From Investing Activities	0.000	-12.01K
Cash From Financing Activities	-43.92K	-23.40K	322.7K
Net Change In Cash	-459.6K	-410.9K	27.27K
YoY Change	446.39%	-1606.97%	-19.25%
FREE CASH FLOW
Cash From Operating Activities	-$415.6K	-$375.5K	-$295.5K
Capital Expenditures	$0.00	-$12.01K
Free Cash Flow	-$415.6K	-$363.5K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	396019	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	319921	USD
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	252285750
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0002
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0002
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000
CY2021Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	345000
CY2021Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	345000
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	345000
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	345000
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1500000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1500000000
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	251385754
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	251385754
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	213751145
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	213751145
CY2021Q2	us-gaap	Cash Cash	4816728	USD
CY2020Q4	us-gaap	Cash Cash	22219	USD
CY2021Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	110195	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	179963	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	4926923	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	202182	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1030918	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1059026	USD
CY2021Q2	us-gaap	Goodwill Goodwill	166000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	166000	USD
CY2021Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	31696	USD
CY2020Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	18946	USD
CY2021Q2	crtg	Assets Excluding Property And Equipment Noncurrent AssetsExcludingPropertyAndEquipmentNoncurrent	1228614	USD
CY2020Q4	crtg	Assets Excluding Property And Equipment Noncurrent AssetsExcludingPropertyAndEquipmentNoncurrent	1243972	USD
CY2021Q2	us-gaap	Assets Assets	6155537	USD
CY2020Q4	us-gaap	Assets Assets	1446154	USD
CY2021Q2	us-gaap	Notes Payable Current NotesPayableCurrent	0	USD
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	46580	USD
CY2021Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	319921	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	442599	USD
CY2021Q2	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	1228991	USD
CY2020Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	266598	USD
CY2021Q2	us-gaap	Liabilities Liabilities	1548912	USD
CY2020Q4	us-gaap	Liabilities Liabilities	709197	USD
CY2021Q2	us-gaap	Preferred Stock Value PreferredStockValue	69	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	69	USD
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	50276	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	42750	USD
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14995892	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	8033313	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10439612	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7339175	USD
CY2020Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	202710642
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	235063138
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	198166791
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	736957	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	50000	USD
CY2021Q1	crtg	Stock Issued During Period Value Issued For Liabilities StockIssuedDuringPeriodValueIssuedForLiabilities	70264	USD
CY2021Q1	crtg	Stock Issued During Period Value Stock Options Exchanged For Common Shares StockIssuedDuringPeriodValueStockOptionsExchangedForCommonShares	0	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4913200	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	4606625	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	736957	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6155537	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1446154	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	0	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	0	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	0	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	0	USD
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	198394	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	36096	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	235996	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	79991	USD
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2517170	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	198141	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2859628	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	464114	USD
CY2021Q2	us-gaap	Interest Expense InterestExpense	72576	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	56645	USD
	us-gaap	Interest Expense InterestExpense	130938	USD
	us-gaap	Interest Expense InterestExpense	277084	USD
CY2021Q2	us-gaap	Costs And Expenses CostsAndExpenses	2788140	USD
CY2020Q2	us-gaap	Costs And Expenses CostsAndExpenses	290882	USD
	us-gaap	Costs And Expenses CostsAndExpenses	3226562	USD
	us-gaap	Costs And Expenses CostsAndExpenses	821189	USD
CY2021Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	USD
CY2020Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1250	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1250	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2788140	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-289632	USD
	us-gaap	Net Income Loss NetIncomeLoss	-3226562	USD
	us-gaap	Net Income Loss NetIncomeLoss	-819939	USD
CY2021Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.011
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.001
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.014
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.004
CY2021Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	247060586
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	62785	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	18723	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-438422	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	4550732	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	180000	USD
CY2021Q2	crtg	Stock Issued During Period Value Issued For Liabilities StockIssuedDuringPeriodValueIssuedForLiabilities	323310	USD
CY2021Q2	crtg	Stock Issued During Period Value Stock Options Exchanged For Common Shares StockIssuedDuringPeriodValueStockOptionsExchangedForCommonShares	0	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2340723	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2788140	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	4606625	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	680465	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	300000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	53447	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	310303	USD
	crtg	Stock Options Exchanged For Common Stock StockOptionsExchangedForCommonStock	420	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-530307	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	813908	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	23692	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	191839	USD
CY2020Q2	crtg	Stock Issued During Period Value Stock Options Exchanged For Common Shares StockIssuedDuringPeriodValueStockOptionsExchangedForCommonShares	0	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-289632	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	739807	USD
	us-gaap	Net Income Loss NetIncomeLoss	-3226562	USD
	us-gaap	Net Income Loss NetIncomeLoss	-819939	USD
	us-gaap	Depreciation Depreciation	0	USD
	us-gaap	Depreciation Depreciation	126	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	40115	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	40115	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	57752	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	241776	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	2359446	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	0	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-69768	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-55479	USD
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	12750	USD
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-0	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	317476	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-137632	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-394755	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-620075	USD
	crtg	Payments For Website Costs PaymentsForWebsiteCosts	12007	USD
	crtg	Payments For Website Costs PaymentsForWebsiteCosts	-0	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	46580	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	33546	USD
	crtg	Proceeds From Debt And Warrants Issued ProceedsFromDebtAndWarrantsIssued	334651	USD
	crtg	Proceeds From Debt And Warrants Issued ProceedsFromDebtAndWarrantsIssued	703249	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4913200	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5201271	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	669703	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4794509	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	49628	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22219	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	58149	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4816728	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	107777	USD
	us-gaap	Interest Paid Net InterestPaidNet	33753	USD
	us-gaap	Interest Paid Net InterestPaidNet	36280	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	230000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	300000	USD
	crtg	Stock Options Exchanged For Common Stock StockOptionsExchangedForCommonStock	0	USD
	crtg	Stock Issued To Settle Liabilities From Services Received StockIssuedToSettleLiabilitiesFromServicesReceived	393574	USD
	crtg	Stock Issued To Settle Liabilities From Services Received StockIssuedToSettleLiabilitiesFromServicesReceived	0	USD
	crtg	Recognition Of Beneficial Conversion Feature RecognitionOfBeneficialConversionFeature	0	USD
	crtg	Recognition Of Beneficial Conversion Feature RecognitionOfBeneficialConversionFeature	502142	USD
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><i>Reclassification</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Certain amounts in the prior period condensed statement of operations have been reclassified to conform to the presentation of the current year. These reclassifications had <em style="font: inherit;">no</em> effect on the previously reported net loss.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	224679849
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	49122797
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt;"><i>Use of Estimates</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from the estimates and assumptions used.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q2	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	1228991	USD
CY2020Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	266598	USD
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2190000
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.0520
	crtg	Class Of Warrant Or Right Issued Monthly ClassOfWarrantOrRightIssuedMonthly	88914000
	crtg	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice	0.0812
CY2021Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	142604000
CY2021Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.0515
	crtg	Class Of Warrant Or Right Contractual Term ClassOfWarrantOrRightContractualTerm	P4Y3M18D
CY2021Q2	crtg	Class Of Warrant Or Right Intrinsic Value ClassOfWarrantOrRightIntrinsicValue	10156953	USD
CY2020Q2	crtg	Share Exchange Agreement Number Of Options Authorized ShareExchangeAgreementNumberOfOptionsAuthorized	21500000
CY2020Q2	crtg	Share Exchange Agreement Exchange Ratio ShareExchangeAgreementExchangeRatio	0.6	pure
	crtg	Share Based Compensation Arrangement By Share Based Payment Award Options Exchanged ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExchanged	3500000
	crtg	Stock Issued During Period Shares Stock Options Exchanged For Common Shares StockIssuedDuringPeriodSharesStockOptionsExchangedForCommonShares	2100000
CY2021Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	650103	USD
CY2021Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	39711609
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P4Y1M17D
CY2021Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	34211609
	us-gaap	Operating Lease Expense OperatingLeaseExpense	7560	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	18032	USD

Files In Submission

Name	View Source	Status
0001437749-21-019381-index-headers.html	Edgar Link	pending
0001437749-21-019381-index.html	Edgar Link	pending
0001437749-21-019381.txt	Edgar Link	pending
0001437749-21-019381-xbrl.zip	Edgar Link	pending
crtg-20210630.xsd	Edgar Link	pending
crtg-20210630_cal.xml	Edgar Link	unprocessable
crtg-20210630_def.xml	Edgar Link	unprocessable
crtg-20210630_lab.xml	Edgar Link	unprocessable
crtg-20210630_pre.xml	Edgar Link	unprocessable
crtg20210630_10q.htm	Edgar Link	pending
crtg20210630_10q_htm.xml	Edgar Link	completed
ex_272397.htm	Edgar Link	pending
ex_272398.htm	Edgar Link	pending
ex_272399.htm	Edgar Link	pending
ex_272400.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRTG
CORETEC GROUP INC. Stock $crtg

2021 Q3 Form 10-Q Financial Statement

#000143774921019381 Filed on August 11, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRTG CORETEC GROUP INC. Stock $crtg

2021 Q3 Form 10-Q Financial Statement

#000143774921019381 Filed on August 11, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRTG
CORETEC GROUP INC. Stock $crtg